Ironwood Pharmaceuticals, Inc.

Ironwood Pharmaceuticals, Inc.verified

IRWD

Price:

$5.7

Market Cap:

$906.05M

Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZESS name in the United States and Mexico, as well as under the CONSTELLA name in the Canada and European Union. The company is also developing IW-3300, a GC-C agonist for the treatment of visceral pain conditions, including interstitial cystitis/bladder pain syndrome and endometriosis; and CNP-104, an immune nanoparticle for the treatment of biliary ch...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2010-02-03

Stock Exchange

NASDAQ

Ticker

IRWD

The PE Ratio as of June 2024 (TTM) for Ironwood Pharmaceuticals, Inc. (IRWD) is -0.84

According to Ironwood Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.84. This represents a change of -99.28% compared to the average of -116.99 of the last 4 quarters.

Ironwood Pharmaceuticals, Inc. (IRWD) Historical PE Ratio (quarterly & annually)

How has IRWD PE Ratio performed in the past?

The mean historical PE Ratio of Ironwood Pharmaceuticals, Inc. over the last ten years is -18.01. The current -0.84 PE Ratio has changed 366.35% with respect to the historical average. Over the past ten years (40 quarters), IRWD's PE Ratio was at its highest in in the March 2020 quarter at 119.43. The PE Ratio was at its lowest in in the December 2023 quarter at -410.49.

Quarterly (TTM)
Annual

Average

-18.01

Median

-8.33

Minimum

-135.61

Maximum

17.10

Ironwood Pharmaceuticals, Inc. (IRWD) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Ironwood Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 2.32%

Maximum Annual PE Ratio = 17.10

Minimum Annual Increase = -116.24%

Minimum Annual PE Ratio = -135.61

Quarterly (TTM)
Annual
YearPE RatioChange
2023-1.77-116.24%
202210.93205.18%
20213.58-79.07%
202017.10-112.61%
2019-135.612.32%
2018-5.60-70.57%
2017-19.03-29.85%
2016-27.12134.84%
2015-11.554.48%
2014-11.05124.20%

Ironwood Pharmaceuticals, Inc. (IRWD) Average PE Ratio

How has IRWD PE Ratio performed in the past?

The current PE Ratio of Ironwood Pharmaceuticals, Inc. (IRWD) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

4.24

5-year avg

-21.15

10-year avg

-18.01

Ironwood Pharmaceuticals, Inc. (IRWD) PE Ratio vs. Peers

How is IRWD’s PE Ratio compared to its peers?

Ironwood Pharmaceuticals, Inc.’s PE Ratio is less than Neurocrine Biosciences, Inc. (35.33), less than Amphastar Pharmaceuticals, Inc. (12.48), less than Collegium Pharmaceutical, Inc. (11.14), less than ANI Pharmaceuticals, Inc. (32.63), less than Alkermes plc (9.44), greater than Intra-Cellular Therapies, Inc. (-65.95), greater than Deciphera Pharmaceuticals, Inc. (-11.74), less than Pacira BioSciences, Inc. (18.60), greater than Avadel Pharmaceuticals plc (-9.12), less than Eagle Pharmaceuticals, Inc. (2.71), less than Assertio Holdings, Inc. (-0.31), greater than Esperion Therapeutics, Inc. (-5.32),

Build a custom stock screener for Ironwood Pharmaceuticals, Inc. (IRWD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ironwood Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ironwood Pharmaceuticals, Inc. (IRWD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ironwood Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Ironwood Pharmaceuticals, Inc.'s PE Ratio?

How is the PE Ratio calculated for Ironwood Pharmaceuticals, Inc. (IRWD)?

What is the highest PE Ratio for Ironwood Pharmaceuticals, Inc. (IRWD)?

What is the 3-year average PE Ratio for Ironwood Pharmaceuticals, Inc. (IRWD)?

What is the 5-year average PE Ratio for Ironwood Pharmaceuticals, Inc. (IRWD)?

How does the current PE Ratio for Ironwood Pharmaceuticals, Inc. (IRWD) compare to its historical average?